skip to content

Our role in diabetes care

Our vision is to help people with diabetes everywhere in the world think less about their daily diabetes routine so they can experience true relief, day and night.

An elderly man in a blue sweater attentively listens to a doctor explaining medical data displayed on a monitor during a consultation in a modern clinical setting.
A global leader in integrated Personalised Diabetes Management

Being a global leader in integrated Personalised Diabetes Management (iPDM), Roche aims to transform and advance care provision and foster sustainable care structures.

iPDM is a structured and value-based therapy approach enabled by digital health solutions designed to improve therapy outcomes in diabetes.

We develop solutions to facilitate personalised care for all people with diabetes wherever they may be in their diabetes journey, whilst ensuring they remain the focus of our approach.

Our diabetes care products

A smiling elderly woman with gray hair wearing a teal long-sleeve shirt listens to earphones while holding a smartphone outdoors on a sunny day with trees and a path nearby

For people with diabetes

In the UK, under the brands Accu-Chek® and mySugr®, Roche offers people with diabetes innovative blood glucose monitoring solutions that connect what counts. Consisting of a connected blood glucose meter, a diabetes management mobile app and a lancing device that help reduce the hassles of day-to-day diabetes management and contribute to improved outcomes.

For healthcare professionals

Accu-Chek serves as the link connecting healthcare professionals with their patients’ health data, enabling well-informed and impactful decision-making. Our diabetes management solution is designed to streamline workflows, encourage efficient patient consultations, and bring value to patient care across multiple healthcare settings.

Digital health monitoring system showing a smartwatch, smartphone, and laptop screen with patient data including charts, graphs, and progress indicators for user John Smith in a modern interface.

M-GB-00011730 Date of Preparation March 2023